Genomics and Translational Genetics
The Genomics and Translational Genetics Service (SGGT) has launched in 2013 as a biotechnological service at Principe Felipe Research Centre (CIPF) that integrates the scientific capacity of the CIPF research groups in human genetics, genomics and bioinformatics with the knowledge and experience in genetic diagnosis of a team of CIPF geneticists and physicians. With this new structure we are taking a step beyond the genomic analysis that CIPF has been providing since 2005, offering integrated genetic testing and analysis of the human genome moving forward to translational medicine and its application in the clinical praxis.
Our mission is to provide support services to clinical and health care, by specializing in genetic testing of single gene diseases, birth defects, chromosomal and genomic syndromes, intellectual disability and other diseases with genetic component, in order to provide diagnosis and genetic counseling, improving health care for patients and their families.
The SGGT aims to:
• To provide technical and clinical support to health professionals interested in genetic diagnosis, addressing the needs that arise in daily clinical practice. To do this, we have a long history in the genetic analysis of hereditary diseases and, consequently, the experience to resolve the issues that may be rise in this regard.
• To innovate in genetic testing by development of new tools based on the technology of ultrasequencing (NGS, 'Next Generation Sequencing') in order to accelerate genetic analysis and molecular diagnostics of disorders with a wide genetic heterogeneity.
• To provide researchers with the technical, material and human resources in the field of DNA Sanger sequencing, genomic analysis using microarray (aCGH-Comparative Genomic Hybridization-, Single-Nucleotide Polymorphisms -aSNP- and Copy Number Variations -CNV-) and other related services such as the extraction, purification and concentration and quality control of DNA and RNA samples.
• To investigate the genetic causes and mechanisms underlying inherited disorders and deepen the knowledge currently exists about these diseases, offering collaborations with research groups within the Program in Rare and Genetic Diseases, always with the aim of get new biomarkers and new therapeutic targets.